Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOMs: BUP-XR vs BUP-SL for OUD in Pregnancy
NCT03918850Phase 3Completed
- Start
- Jul 2020
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of buprenorphine extended-release injection in opioid use disorder (OUD) (2 arms). Primary endpoint: Percentage of Illicit Opioid-negative Urine Samples During Pregnancy. Started Jul 2020; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03918850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03918850.